Program Director, In Vivo Preclinical Programs at Regel Therapeutics
Seattle, Washington, United States
Join Prog.AI to see contacts
Join Prog.AI to see contacts
Summary
👤
Senior
🎓
Top School
Perry Spratt is a neuroscientist-turned-program director based in Seattle with a decade-plus of research experience and eight years in industry leadership guiding in vivo preclinical and CNS programs. At Regel Therapeutics he progressed from senior scientist to program director, overseeing translational in vivo studies and aligning preclinical strategies with therapeutic goals. His PhD and postdoctoral work at UCSF produced mechanistic insights into SCN2A-related neurodevelopmental disorders and led to collaborative gene-therapy and sensor-development projects. He brings hands-on assay and software development experience—authoring Python and MATLAB tools for electrophysiology, imaging, and behavioral tracking—that streamline data analysis across labs. Known for translating complex electrophysiology and imaging methods into robust assays for freely-behaving rodents, he combines technical rigor with cross-functional coordination. Perry’s background blends deep academic discovery with practical program leadership and a proven track record of turning mechanistic findings into preclinical progress.
8 years of coding experience
6 years of employment as a software developer
Doctor of Philosophy (Ph.D.), Neuroscience, Doctor of Philosophy (Ph.D.), Neuroscience at University of California, San Francisco
Bachelor’s Degree, Honours Neuroscience, Bachelor’s Degree, Honours Neuroscience at McGill University
Contributions:44 pushes, 1 branch in 1 year 6 months
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.
Request Free Trial
Perry Spratt - Program Director, In Vivo Preclinical Programs at Regel Therapeutics